徐晋徉,何常,胡斌
XU Jinxiang,HE Chang,HU Bin

• 1:贵州医科大学附属医院病理科

摘要(Abstract)：

目的:探讨Ig A肾病组织中肾素-血管紧张素(RAS)系统相关蛋白脯氨酰羧基肽酶(PRCP)、血管紧张素转化酶2(ACE2)的表达及意义。方法:选取54例Ig A肾病患者[20例局灶增生性Ig A肾病、20例Ig A肾病合并膜性肾病(MN)及14例新月体性Ig A肾病)]的肾穿刺组织标本作为Ig A肾病组,20例微小病变肾病(MCD)的肾穿刺组织标本作为对照组,采用免疫组化法检测2组患者肾穿刺组织的PRCP、ACE2表达,分析PRCP、ACE2表达与各类型Ig A肾病病变程度的关系。结果:PRCP、ACE2在Ig A肾病组的表达量高于对照组(P<0. 05);在Ig A肾病组,随着患者的病变程度的加重,PRCP、ACE2蛋白在肾小球区域的表达呈逐渐上升趋势,而在肾小管区域的表达量呈下降趋势,差异有统计学意义(P <0. 05); PRCP与Ig A在肾小球的沉积存在负相关(r=-0. 301,P=0. 027),ACE2与Ig A在肾小球的沉积存在正相关(r=0. 306,P=0. 024)。结论:PRCP、ACE2在Ig A肾病的肾组织中表达,并随着病变加重,表达水平在肾小球和肾小管区域呈不同趋势。
Objective: To investigate the expression and significance of prolyl carboxypeptidase( PRCP) and angiotensin converting enzyme 2( ACE2) in IgA nephropathy. Methods: Renal biopsy specimens from 54 patients [20 cases of focal proliferative IgA nephropathy,20 cases of IgA nephrotic syndrome with membranous nephropathy( MN) and 14 cases of crescent IgA nephropathy] with IgA nephropathy were selected as IgA nephropathy group. The PRCP and ACE2 expression of renal puncture tissue in 20 patients with minimal lesion nephropathy( MCD) was detected by immunohistochemistry in the control group to analyze the relationship between PRCP as well as ACE2 expression and the degree of IgA nephropathy. Results: The expression of PRCP and ACE2 in IgA nephropathy group was higher than that in control group( P < 0. 05). The expression of PRCP and ACE2 protein increased gradually in the glomerular region and decreased in the renal tubule region in the IgA nephropathy group with the increase of lesion degree,and the difference was statistically significant( P < 0. 05). PRCP was negatively correlated with IgA deposition in glomeruli( r =-0. 301,P = 0. 027) and positively correlated with IgA deposition in glomeruli( r = 0. 306,P = 0. 024).Conclusion: PRCP and ACE2 are expressed in the renal tissue of IgA nephropathy,and with the aggravation of the lesion,the expression level shows different trends in the glomerular and tubular regions.

关键词(KeyWords)： 肾小球肾炎,IgA;肾素-血管紧张素系统;免疫组织化学;血管紧张素转化酶2;脯氨酰羧基肽酶
glomerulonephritis,IgA;renin-angiotensin system;immunohistochemistry;angiotensin converting enzyme 2(ACE2);prolylcarboxypeptidase(PRCP)

Abstract:

Keywords:

基金项目(Foundation): 贵州省科学技术厅基金项目[黔科合J(2010)2158]

作者(Author): 徐晋徉,何常,胡斌
XU Jinxiang,HE Chang,HU Bin

DOI: 10.19367/j.cnki.2096-8388.2020.05.016

参考文献(References)：

• [1]RODRIGUES J C,HAAS M,REICH H N. Ig A Nephropathy[J]. Clin J Am Soc Nephrol,2017,12(4):677-686.
• [2]SOARES M F. An update on pathology of Ig A nephropathy[J]. J Bras Nefrol,2016,38(4):435-440.
• [3]PRAGA M,CARAVACA F,YUSTE C,et al. Ig A nephropathy:what patients are at risk of progression to endstage renal disease and how should they be treated[J].Nefrologia,2018,38(4):347-352.
• [4]ZHANG L,LIU X,PASCOE E M,et al. Long-term outcomes of end-stage kidney disease for patients with Ig A nephropathy:A multi-centre registry study[J]. Nephrology(Carlton),2016,21(5):387-396.
• [5] OHASHI N,ISOBE S,CAAMAL-LEY A D,et al.Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive Ig A nephropathy patients[J]. Hypertens Res,2018,41(5)3:314-341.
• [6]TANAKA S,NINOMIYA T,KATAFUCHI R,et al. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in Ig A nephropathy[J].Clin Exp Nephrol,2016,20(5):689-698.
• [7]于萍，步宏，王华，等．免疫组化结果的图像分析与人工计数方法的对比研究[J]．生物医学工程学杂志，2003,2(2):288-290.
• [8]WANG C J,ZHOU Z G,HOLMQVIST A,et al. Survivin expression quantified by Image Pro-Plus compared with visual assessment[J]. Appl Immunohistochem Mol Morphol,2009,17(6):530-535.
• [9]闻妹，陈映霞，秦叔逵，等．贝伐珠单抗诱导小鼠蛋白尿的形成机制[J]．医学研究生学报，2016,29(8):812-817.
• [10]邹万忠．肾活检病理学[M]. 4版．北京大学医学出版社，2017:25-40.
• [11]WOO K T,FOO M,CHOONG H L,et al. The incidence of Ig A nephropathy is associated with socioeconomic deprivation[J]. Kidney Int,2014,86(3):651-652.
• [12]LEMLEY K V,LAFAYETTE R A,DERBY G,et al.Prediction of early progression in recently diagnosed Ig A nephropathy[J]. Nephrol Dial Transplant,2008,23(1):213-222.
• [13]PLACZEK W J,YANAGAWA H,MAKITA Y,et al.Serum galactose-deficient-IgA1 and Ig G autoantibodies correlate in patients with Ig A nephropathy[J]. PLo S One,2018,13(1):1-9.
• [14]CORVOL P. History of the discovery of the renin-angiotensin system[J]. Rev Prat,2018,68(8):917-926.
• [15]KOBORI H,NANGAKU M,NAVAR L G,et al. The intrarenal renin-angiotensin system:from physiology to the pathobiology of hypertension and kidney disease[J].Pharmacol Rev,2007,59(3):251-287.
• [16]KROCHMAL M,CISEK K,FILIP S,et al. Identification of novel molecular signatures of Ig A nephropathy through an integrative-omics analysis[J]. Sci Rep,2017,7(1):90-91.
• [17]TABRIZIAN T,HATAWAY F,MURRAY D,et al.Prolylcarboxypeptidase gene expression in the heart and kidney:Effects of obesity and diabetes[J]. Cardiovascular&hematological agents in medicinal chemistry,2015,13(2):113-123.
• [18]任翔，孙嘉，王明．血管紧张素转换酶2与糖尿病肾病[J]．国际内分泌代谢杂志，2014,34(1):53-56.
• [19]GILBERT A,LIU J,CHENG G,et al. A review of urinary angiotensin converting enzyme 2 in diabetes and diabetic nephropathy[J]. Biochem Med,2019,29(1):1-5.
• [20]ZOU Y,YANG M,DU X. New insight into the management of Ig A nephropathy[J]. Clin Exp Nephrol,2018,22(6):1442-1443.
• [21]YANAGIHARA R,BROWN S,HALL,et al. In vitrogenerated immune complexes containing galactose-deficient Ig A1 stimulate proliferation of mesangial cells[J].Results in immunology,2012,2:166-172.

文章评论(Comment)：